Taiwan Liposome Company, Ltd.;TLC Biopharmaceuticals, Inc.
发明人:
HONG, Keelung,GUO, Luke S.S.,TSENG, Yun-Long,SHIH, Sheue-Fang,CHANG, Po-Chun,TSAI, Chih-Chiang,LIN, Hong-Hui
申请号：
DK13747021
公开号：
DK2797601T3
申请日:
2013.02.08
申请国别(地区):
DK
年份:
2018
代理人:
摘要：
The present invention relates to pharmaceutical compositions comprising a combination of a lipid cake mixture comprising one or more phospholipids, with or without cholesterol, and a steroid solution comprising an ocular steroid, derivative thereof a pharmaceutically acceptable salt thereof or a prodrug thereof, wherein the total amount of the phospholipid in the said composition is about 0.1 umol to less than about 2.5 umol per 50 ul of pharmaceutical composition and the side effects of the ocular steroid are reduced. The pharmaceutical composition is preferably administered by ocular route to treat ophthalmic diseases.
